Revisions to the criteria are led by The ASAM Criteria Editorial Team with oversight from ASAM’s ASAM Criteria Strategy Steering Committee, Quality Improvement Council and Board of Directors. The Coalition for National Clinical Criteria provides substance use disorder input throughout the process. The Coalition represents major stakeholders in addiction treatment and has been meeting regularly since the development of the first ASAM Patient Placement Criteria in 1991.
United States Electronically Scanned Arrays Market Size, Emerging Tech, Trends & Strategy 2026-2033
AI-driven predictive maintenance, digital twins, and smart production systems are enhancing productivity and cost control. Regulatory alignment, data security, and sustainable technology adoption play a central role in shaping long-term market strategies. Across North America, the market is witnessing rapid digital transformation driven by enterprise-scale automation, data intelligence, and cloud-enabled AI solutions. Organizations are prioritizing efficiency gains, cost optimization, and operational resilience through advanced analytics and intelligent systems.
Aluminum Brazing Sheets Market Size, Emerging Tech, Digital Transformation & CAGR 2026-2033
However, while the effects of prevention interventions remained significant at follow‐ups of up to 12 months, effects of treatment interventions did not257. A recent meta‐analysis245 concluded that, for alcohol use disorder, there was high‐quality evidence that manualized twelve‐step interventions are as effective or even more effective than other treatments such as CBT for increasing abstinence. However, the evidence of superiority of these interventions for other SUDs is weaker245. About 40% of people with a SUD report not being ready to stop using, highlighting the role of motivation in the treatment process217. Motivational interviewing has the best empirical support among approaches that convey empathy and minimize confrontation218.
ASAM Criteria
Social workers can also help by participating in Individualized Education Plan (IEP) meetings, making school referrals for special education, and requesting psychoeducational and neuropsychological testing. Referral to a child and adolescent psychiatrist for a medication evaluation may also be helpful as well as assisting teachers with behavioral interventions in the classroom. The family context holds information about how SUDs develop, are maintained, and what can positively or negatively influence the treatment of the disorder. Family systems theory and attachment theory are theoretical models that provide a framework for understanding how SUDs affect the family. In addition, understanding the current developmental stage a family is in helps inform assessment of impairment and determination of appropriate interventions.
- Regulations on safety, quality, and environmental compliance can vary widely across regions.
- However, when contrasted with any specific therapy, CBT’s effects were consistently non‐significant across outcomes and follow‐up time points235.
- Social workers can encourage parents of adult children to seek their own help in Al-Anon and Nar-Anon.
- Although that adaptation may keep the family system in a state of equilibrium, it also serves to maintain the problem.
Key Players Analysis provides an overview of the market’s participant landscape, highlighting the strategic positioning, operational focus, and capability distribution across leading and emerging entities. It evaluates how participants are adapting to demand shifts, technology adoption, pricing pressures, and regulatory expectations to sustain competitiveness and long-term market relevance. Substance use disorders affect the brain and behavior, causing difficulties in work, school, or in relationships.
Another consideration when selecting a medication for opioid use disorder is whether there are any co‐occurring disorders. For example, naltrexone is also effective in treating alcohol use disorder129, whereas buprenorphine’s kappa opioid receptor antagonist properties may offer benefits for individuals with comorbid depression. Methadone or buprenorphine are recommended for pregnant women, as there are insufficient data on naltrexone’s safety in this population. For patients with a history of cardiac arrhythmias, methadone might be contraindicated, due to its QT‐prolongation effects, which do not occur with buprenorphine or naltrexone. There is a growing consensus that SUDs, once developed, tend to be chronic disorders161, reflecting long‐lasting changes in brain function50, 51, that are exacerbated by the cumulative mental health and social consequences that they trigger.
Management and Treatment
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions and related disorders. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients. Adial is currently planning to conduct a new Phase 3 clinical trial program for the treatment of AUD in subjects with certain target genotypes identified using the Company’s proprietary diagnostic genetic test. ONWARD showed promising results in reducing drinking in heavy drinking patients, with no overt safety or tolerability concerns.